CTLA-4 Blockade following Relapse of Malignancy after Allogeneic Stem Cell Transplantation Is Associated with T Cell Activation But Not with Increased Levels of T Regulatory Cells
Open Access
- 31 May 2011
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 17 (5), 682-692
- https://doi.org/10.1016/j.bbmt.2010.08.005
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Immunosuppressive Strategies that are Mediated by Tumor CellsAnnual Review of Immunology, 2007
- Regulatory T cells in immune surveillance and treatment of cancerSeminars in Cancer Biology, 2006
- Analysis of the Cellular Mechanism of Antitumor Responses and Autoimmunity in Patients Treated with CTLA-4 BlockadeThe Journal of Immunology, 2005
- Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4Journal of Clinical Oncology, 2005
- Anti–human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodiesBlood, 2005
- Association of Foxp3 regulatory gene expression with graft-versus-host diseaseBlood, 2004
- Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T CellsPublished by The American Association of Immunologists ,2004
- Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cellsBlood, 2004
- Regulation of Surface and Intracellular Expression of CTLA‐4 on Human Peripheral T CellsScandinavian Journal of Immunology, 2001
- Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral BloodThe Journal of Experimental Medicine, 2001